MRA Countdown: 10, 6, 4, 2, ...
Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Register now for ECA's GMP Newsletter
The Mutual Recognition Agreement (MRA) with the US is on track. In a press announcement from 11 June the EMA informed that Luxembourg and the Netherlands have joined the agreement for good manufacturing practice (GMP) inspections between the US Food and Drug Administration (FDA) and EU Member States.
Now 26 countries are included. Germany and Slovakia are the only EU member states that have not been added yet. By 15 July 2019, however, all authorities and countries should have been approved and acknowledged by FDA.
If the agreement is in force (and only then!), the additional full testing of a drug imported from the USA will no longer be necessary. This also applies to countries that have already been recognised.
Source: EMA press release entitled "Two additional countries to benefit from EU-US mutual recognition agreement for inspections".
Related GMP News
30.04.2025QP Declaration: New Q&As published
19.03.2025Root Cause Analysis: Again, problems discovered in GMP-Inspections
19.03.2025ICMRA publishes Hybrid Inspection Pilot Summary Report
19.03.2025From Burkholderia to Ethylene Glycol - a List of Deficiencies at a Manufacturer of OTC Products
19.03.2025Warning Letter - Deficiencies in the Control of Raw and Starting Materials
19.03.2025Inadequate Microbiological Testing of Nonsterile Products - FDA Warning Letter